Role of nitric oxide in host defense against an extracellular, metazoan parasite, Brugia malayi

被引:100
作者
Rajan, TV
Porte, P
Yates, JA
Keefer, L
Shultz, LD
机构
[1] OAKLAND UNIV,DEPT BIOL,ROCHESTER,MI 48063
[2] NCI,FREDERICK CANC RES & DEV CTR,FREDERICK,MD
[3] JACKSON LAB,BAR HARBOR,ME 04609
关键词
D O I
10.1128/IAI.64.8.3351-3353.1996
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The mechanisms by which mammalian hosts eliminate microparasites such as bacteria and viruses are well established, In viral infections, these mechanisms include the interferons, neutralizing and opsonizing antibodies, and cytotoxic T lymphocytes. In bacterial infections, polymorphonuclear leukocytes and macrophages, often facilitated by opsonizing antibodies, ingest the infectious agent and mediate host defense, In addition, complement, in the presence of specific antibodies directed against surface antigens, can lyse certain bacterial pathogens, In contrast, our understanding of the host defenses against metazoan, extracellular parasites is less well grounded, We obtained data by two different approaches to document the role of nitric oxide (NO) as a mediator of host defense against a human nematode parasite, First, treatment of immunocompetent, nonpermissive mice with an inhibitor of NO synthase abrogated resistance to Brugia malayi, one of the causative agents of human lymphatic filariasis, Second, treatment of permissive, immunodeficient mice with a compound that releases NO conferred resistance to infection, These data reinforce studies by James and her coworkers (I. P. Oswald, T. A. Wynn, A. Sher, and S. L. James, Comp. Biochem. Physiol. Pharmacol. Toxicol. Endocrinol. 108:11-18, 1994) on the role of NO in defense against trematode parasites and of Kanazawa et al. (T, Kanazawa, H. Asahi, H. Hata; K. Machida, N. Kagei, and M. J. Stadecker, Parasite Immunol. 15:619-623, 1993) on cestode parasites.
引用
收藏
页码:3351 / 3353
页数:3
相关论文
共 17 条
[1]  
Albina J E, 1995, New Horiz, V3, P46
[2]   On the expression of nitric oxide synthase by human macrophages. Why no NO? [J].
Albina, JE .
JOURNAL OF LEUKOCYTE BIOLOGY, 1995, 58 (06) :643-649
[3]  
Brzozowski T, 1991, J Physiol Pharmacol, V42, P181
[4]   PROTECTIVE IMMUNITY TO BRUGIA-MALAYI LARVAE IN BALB/C MICE - POTENTIAL OF THIS MODEL FOR THE IDENTIFICATION OF PROTECTIVE ANTIGENS [J].
CARLOW, CKS ;
PHILIPP, M .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1987, 37 (03) :597-604
[5]   AMINOGUANIDINE, A NOVEL INHIBITOR OF NITRIC-OXIDE FORMATION, PREVENTS DIABETIC VASCULAR DYSFUNCTION [J].
CORBETT, JA ;
TILTON, RG ;
CHANG, K ;
HASAN, KS ;
IDO, Y ;
WANG, JL ;
SWEETLAND, MA ;
LANCASTER, JR ;
WILLIAMSON, JR ;
MCDANIEL, ML .
DIABETES, 1992, 41 (04) :552-556
[6]  
JAMES SL, 1995, MICROBIOLOGY, V59, P535
[7]   ARGININE-DEPENDENT GENERATION OF REACTIVE NITROGEN INTERMEDIATES IS INSTRUMENTAL IN THE IN-VITRO KILLING OF PROTOSCOLECES OF ECHINOCOCCUS-MULTILOCULARIS BY ACTIVATED MACROPHAGES [J].
KANAZAWA, T ;
ASAHI, H ;
HATA, H ;
MOCHIDA, K ;
KAGEI, N ;
STADECKER, MJ .
PARASITE IMMUNOLOGY, 1993, 15 (11) :619-623
[8]   NITRIC-OXIDE - A NEW PARADIGM FOR 2ND-MESSENGERS [J].
KERWIN, JF ;
LANCASTER, JR ;
FELDMAN, PL .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (22) :4343-4362
[9]   NATURAL-RESISTANCE AND NITRIC-OXIDE [J].
NATHAN, C .
CELL, 1995, 82 (06) :873-876
[10]  
NATHAN C, 1994, J BIOL CHEM, V269, P13725